Medication-Assisted Treatment (MAT) programs are increasingly recognized as essential tools in addressing opioid addiction within the prison system. When an individual uses heroin, even a single time, the risk of addiction is significant. The OCR content highlights that once an inmate is started on medications like Suboxone (commonly referred to as 'sub'), they often remain on these treatments indefinitely. While some may view this as unnecessary, MAT programs provide a stabilized, evidence-based approach to managing addiction, minimizing withdrawal symptoms, and reducing the risk of relapse. In correctional facilities, MAT combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. This comprehensive strategy addresses both the physical and psychological aspects of addiction, supporting inmates in their recovery journey. The goal is to reduce overdose deaths, decrease illicit drug use, and increase post-release success. Importantly, MAT offers a path toward rehabilitation that aligns with public health goals and improves inmate well-being. Criticism sometimes arises around the long-term use of MAT medications; however, prolonged treatment is often necessary due to the chronic nature of opioid addiction. Prisons adopting these programs reflect a shift toward humane and effective care, recognizing substance use as a medical condition rather than solely a disciplinary issue. For inmates, MAT can be life-changing—helping to break the cycle of addiction and reducing the likelihood of re-incarceration. If you or a loved one is affected by opioid use in correctional settings, understanding MAT and advocating for expanded treatment options can make a meaningful difference. The conversation around addiction and prison healthcare continues to evolve, emphasizing recovery and rehabilitation as intertwined goals in reducing the social and economic impacts of drug addiction.